Please login to the form below

Not currently logged in

FDA outlines its plans to simplify DTC ads for consumers

Hopes customer-friendly terminology will aid healthcare decisions
FDA headquarters

US regulators have published new draft guidance on direct-to-consumer (DTC) print advertising for pharmaceutical companies and their agencies.

The FDA wants the industry to take a more consumer-friendly approach to the terminology it uses in its print advertising.

It is hoped that by ensuring pharma advertising move away from more technical language consumers will be more aware of a drug's purpose and the potential risks that come with it.

The FDA conducted 11 studies on drug advertising to develop the 'Disclosing risk information in consumer-directed print advertisements and promotional labelling for human prescription drugs' guidance.

There the agency notes: “Research has demonstrated that people process only a limited amount of information at one time both in general communications and in direct-to-consumer prescription drug advertising specifically.”

To make drug information more consumer-friendly, the FDA has recommended companies use terms such as 'drowsiness' over 'somnolence', for example, and write out only “clinically significant information on the most serious and the most common risks associated with the product”.

The FDA's revised draft guidance does not clearly address exactly which warnings and precautions should be included on products and, so far, it's only applicable to print advertising and does not reference other forms, such as television.

It is, however, notable that the FDA has back tracked on its previous guidance stance when it comes to prescribing information (PI).

Now the regulator says: “FDA strongly recommends against the use of the traditional approach to fulfil the brief summary requirement in consumer-directed advertisements, an approach in which risk-related sections of the PI are presented verbatim, often in small font.”

Health literacy remains an issue in the country and in 2006 the US Department of Education published the only national data so far on skills in the area. This showed that, while the majority of adults (53%) had intermediate health literacy, 22% had only basic health literacy skills and 14% had below basic health literacy.

Article by
Kirstie Pickering

13th February 2015

From: Marketing, Regulatory



Featured jobs

Subscribe to our email news alerts


Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...